Clinical trials in neurological diseases often involve subjective, qualitative endpoints, such ‘by eye’ observations of movement. We developed an artificial intelligence–based method to analyze natural daily behavior data from people with Duchenne muscular dystrophy, using machine-learning algorithms to accurately predict their personal disease trajectories better than conventional clinical assessments.
This is a preview of subscription content, log in via an institution to check access.
References
Kennard, C., Munro, A. J. & Park, D. M. The reliability of clinical assessment of Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 47, 322 (1984). This paper discusses the fact that certain clinical scale items depend on the clinician’s subjective judgements rather than their objective judgements.
McDonald, C. M. et al. The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 41, 500–510 (2010). This paper discusses the fact that certain clinical scale items depend on the clinician’s subjective judgements rather than their objective judgements.
Scott, E. et al. Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy. Physiother. Res. Int. 17, 101–109 (2012). This paper introduced the North Star Ambulatory Assessment scale currently used to monitor the progression of DMD.
Kadirvelu, B. et al. Data-derived wearable digital biomarkers predict Frataxin gene expression levels and longitudinal disease progression in Friedreich’s Ataxia. Nat. Med. https://doi.org/10.1038/s41591-022-02159-6 (2023). A paper linked to ours, on an epigenetic neurological disorder assessed by the same behavior ‘fingerprinting’ pipeline that allows prediction of patients’ personal gene expression levels.
Branson, K., Robie, A. A., Bender, J., Perona, P. & Dickinson, M. H. High-throughput ethomics in large groups of Drosophila. Nat. Methods 6, 451–457 (2009). This paper introduces the concept of ethomics in the organism Drosophila melanogaster.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Ricotti, V. et al. Wearable full-body motion tracking of activities of daily living predicts disease trajectory in Duchenne muscular dystrophy. Nat. Med. https://doi.org/10.1038/s41591-022-02045-1 (2023).
Rights and permissions
About this article
Cite this article
Wearables and AI better predict the progression of muscular dystrophy. Nat Med 29, 37–38 (2023). https://doi.org/10.1038/s41591-022-02191-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-022-02191-6
- Springer Nature America, Inc.